Dr J. Penders

Barnett, D., Thijs, C., Mommers, M., Endika, M., Klostermann, C., Schols, H., Smidt, H., Nauta, A., Arts, I., & Penders, J. (2025). Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study. Gut Microbes, 17(1), Article 2485326. https://doi.org/10.1080/19490976.2025.2485326

Schoultz, I., Claesson, M. J., Dominguez-Bello, M. G., Fåk Hållenius, F., Konturek, P., Korpela, K., Laursen, M. F., Penders, J., Roager, H., Vatanen, T., Öhman, L., & Jenmalm, M. C. (2025). Gut microbiota development across the lifespan: Disease links and health-promoting interventions. Journal of Internal Medicine, Article 20089. Advance online publication. https://doi.org/10.1111/joim.20089

Kelderer, F., Granåsen, G., Holmlund, S., Silfverdal, S. A., Bamberg, H., Mommers, M., Penders, J., Domellöf, M., Mogren, I., & West, C. E. (2025). Respiratory Morbidity Before and During the COVID-19 Pandemic from Birth to 18 Months in a Swedish Birth Cohort. Journal of Allergy and Clinical Immunology, 155(4), 1214-1223.e10. https://doi.org/10.1016/j.jaci.2024.12.1080

Endika, M. F., Barnett, D. J. M., Olmos, E. M., Ter Braak, C. J. F., Arts, I. C. W., Penders, J., Nauta, A., Leemhuis, H., Venema, K., & Smidt, H. (2025). Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS microbiology ecology, 101(4), Article fiaf028. https://doi.org/10.1093/femsec/fiaf028

Hillege, L. E., Barnett, D. J. M., Ziemons, J., Aarnoutse, R., de Vos-Geelen, J., van Geel, R., de Boer, M., van Riet, Y. E. A., Vincent, J., Penders, J., & Smidt, M. L. (2025). The gut microbiota during tamoxifen therapy in patients with breast cancer. Scientific Reports, 15(1), Article 7874. https://doi.org/10.1038/s41598-025-91734-1

Pinto, S., Beninca, E., Galazzo, G., Jonkers, D., Penders, J., & Bogaards, J. A. (2024). Heterogeneous associations of gut microbiota with Crohn's disease activity. Gut Microbes, 16(1), Article 2292239. https://doi.org/10.1080/19490976.2023.2292239

Chan, J., Best, N., Arcilla, M., Hattem, J., Melles, D. C., Jong, M. D., Schultsz, C., Genderen, P. J. J., Bootsma, M. C. J., Goorhuis, A., Grobusch, M. P., Oude Lashof, A. M., Verbrugh, H. A., Penders, J., & COMBAT-study consortium (2024). Antimicrobial resistance genes acquisition among Dutch intercontinental travellers: a prospective multicentre study. Journal of Travel Medicine, 31(8), Article taae131. https://doi.org/10.1093/jtm/taae131

Kameli, N., Becker, H. E. F., Jonkers, D. M., Penders, J., Savelkoul, P., & Stassen, F. (2024). Investigating the Immunomodulatory Impact of Fecal Bacterial Membrane Vesicles and Their IgA Coating Patterns in Crohn's Disease Patients. International Journal of Molecular Sciences, 25(23), Article 13194. https://doi.org/10.3390/ijms252313194

Hillege, L. E., Stevens, M. A. M., Kristen, P. A. J., de Vos-Geelen, J., Penders, J., Redinbo, M. R., & Smidt, M. L. (2024). The role of gut microbial ß-glucuronidases in carcinogenesis and cancer treatment: a scoping review. Journal of Cancer Research and Clinical Oncology, 150(11), Article 495. https://doi.org/10.1007/s00432-024-06028-2

van Duuren, I. C., Smits, H. H., Duijts, L., Penders, J., & Tramper-Stranders, G. A. (2024). Luchtwegaandoeningen bij te vroeg geboren zuigelingen: Kunnen bacteriële lysaten dit terugdringen? Tijdschrift voor Infectieziekten, 19(4), 146-152. https://www.tvionline.nl/journal-article/luchtwegaandoeningen-bij-te-vroeg-geboren-zuigelingen-kunnen-bacteriele-lysaten-dit-terugdringen/